We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Mesenchymal-Stem-Cell-Based Strategies for Retinal Diseases.
- Authors
Chen, Xiteng; Jiang, Yuanfeng; Duan, Yanan; Zhang, Xiaomin; Li, Xiaorong
- Abstract
Retinal diseases are major causes of irreversible vision loss and blindness. Despite extensive research into their pathophysiology and etiology, pharmacotherapy effectiveness and surgical outcomes remain poor. Based largely on numerous preclinical studies, administration of mesenchymal stem cells (MSCs) as a therapeutic strategy for retinal diseases holds great promise, and various approaches have been applied to the therapies. However, hindered by the retinal barriers, the initial vision for the stem cell replacement strategy fails to achieve the anticipated effect and has now been questioned. Accumulating evidence now suggests that the paracrine effect may play a dominant role in MSC-based treatment, and MSC-derived extracellular vesicles emerge as a novel compelling alternative for cell-free therapy. This review summarizes the therapeutic potential and current strategies of this fascinating class of cells in retinal degeneration and other retinal dysfunctions.
- Subjects
RETINAL diseases; RETINAL degeneration; VISION disorders; CELL death; EXTRACELLULAR vesicles; MESENCHYMAL stem cells; RETROLENTAL fibroplasia
- Publication
Genes, 2022, Vol 13, Issue 10, pN.PAG
- ISSN
2073-4425
- Publication type
Article
- DOI
10.3390/genes13101901